Connection

SUBRATA SEN to Humans

This is a "connection" page, showing publications SUBRATA SEN has written about Humans.
Connection Strength

0.411
  1. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer. Br J Cancer. 2024 Jul; 131(1):171-183.
    View in: PubMed
    Score: 0.018
  2. eEF1A2 promotes PTEN-GSK3?-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer. Sci Signal. 2024 03 05; 17(826):eadh4475.
    View in: PubMed
    Score: 0.018
  3. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Int J Mol Sci. 2023 Sep 27; 24(19).
    View in: PubMed
    Score: 0.018
  4. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res. 2022 05 02; 28(9):1938-1947.
    View in: PubMed
    Score: 0.016
  5. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prev Res (Phila). 2021 07; 14(7):729-740.
    View in: PubMed
    Score: 0.015
  6. Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol. 2018 06; 78:22-36.
    View in: PubMed
    Score: 0.012
  7. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis. 2016 Dec; 37(12):1180-1189.
    View in: PubMed
    Score: 0.011
  8. Aurora-C Interactions with Survivin and INCENP Reveal Shared and Distinct Features Compared with Aurora-B Chromosome Passenger Protein Complex. PLoS One. 2016; 11(6):e0157305.
    View in: PubMed
    Score: 0.011
  9. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol. 2016 Jan; 231(1):25-30.
    View in: PubMed
    Score: 0.010
  10. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol. 2015 Aug; 47(2):782-90.
    View in: PubMed
    Score: 0.010
  11. Regulation of AURKC expression by CpG island methylation in human cancer cells. Tumour Biol. 2015 Sep; 36(10):8147-58.
    View in: PubMed
    Score: 0.010
  12. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett. 2015 Jan 28; 356(2 Pt B):404-9.
    View in: PubMed
    Score: 0.009
  13. Genetic variation in coding region of Aurora kinase A gene leads to cancer susceptibility. Cancer Epidemiol. 2014 Apr; 38(2):109-10.
    View in: PubMed
    Score: 0.009
  14. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014 Feb 10; 19(2):1912-38.
    View in: PubMed
    Score: 0.009
  15. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell. 2012 Feb 14; 21(2):196-211.
    View in: PubMed
    Score: 0.008
  16. MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. J Biosci. 2011 Aug; 36(3):481-91.
    View in: PubMed
    Score: 0.008
  17. Functional significance of Aurora kinase A regulatory interactions with p53-ERa complex in human breast cancer cells. Horm Cancer. 2011 Apr; 2(2):117-24.
    View in: PubMed
    Score: 0.007
  18. Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta. 2010 Oct-Dec; 1799(10-12):829-39.
    View in: PubMed
    Score: 0.007
  19. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. Horm Cancer. 2010 Feb; 1(1):11-20.
    View in: PubMed
    Score: 0.007
  20. Molecular cytogenetic evidence for multistep tumorigenesis: implications for risk assessment and early detection. Cancer Biomark. 2010; 9(1-6):113-32.
    View in: PubMed
    Score: 0.007
  21. Aurora-C: the youngest of "the three (Aurora kinase) tenors" of mitotic symphony. Cell Cycle. 2009 Oct 01; 8(19):3076-7.
    View in: PubMed
    Score: 0.007
  22. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila). 2009 Sep; 2(9):807-13.
    View in: PubMed
    Score: 0.007
  23. Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells. Cell Cycle. 2008 Sep 01; 7(17):2691-704.
    View in: PubMed
    Score: 0.006
  24. Functional significance of Aurora kinase A in centrosome amplification and genomic instability. Adv Exp Med Biol. 2008; 617:99-108.
    View in: PubMed
    Score: 0.006
  25. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex. J Cell Biochem. 2007 Dec 01; 102(5):1318-31.
    View in: PubMed
    Score: 0.006
  26. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol Res. 2005; 15(1):49-57.
    View in: PubMed
    Score: 0.005
  27. Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil Cytoskeleton. 2004 Dec; 59(4):249-63.
    View in: PubMed
    Score: 0.005
  28. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol. 2004 Dec; 25(6):1631-9.
    View in: PubMed
    Score: 0.005
  29. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Carcinogenesis. 2024 Aug 12; 45(8):582-594.
    View in: PubMed
    Score: 0.005
  30. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet. 2004 Jan; 36(1):55-62.
    View in: PubMed
    Score: 0.004
  31. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003 Dec; 22(4):451-64.
    View in: PubMed
    Score: 0.004
  32. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project. Cancer Res Commun. 2023 10 10; 3(10):2062-2073.
    View in: PubMed
    Score: 0.004
  33. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Clin Chim Acta. 2023 Nov 01; 551:117567.
    View in: PubMed
    Score: 0.004
  34. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res. 2003 Mar; 9(3):991-7.
    View in: PubMed
    Score: 0.004
  35. Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells. Cancer Med. 2023 04; 12(7):8499-8509.
    View in: PubMed
    Score: 0.004
  36. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst. 2002 Sep 04; 94(17):1320-9.
    View in: PubMed
    Score: 0.004
  37. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. J Biol Chem. 2001 Dec 07; 276(49):46219-24.
    View in: PubMed
    Score: 0.004
  38. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorg Chem. 2020 12; 105:104447.
    View in: PubMed
    Score: 0.004
  39. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020 12; 159(6):2146-2162.e33.
    View in: PubMed
    Score: 0.004
  40. Aneuploidy and cancer. Curr Opin Oncol. 2000 Jan; 12(1):82-8.
    View in: PubMed
    Score: 0.003
  41. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. J Proteome Res. 2019 07 05; 18(7):2826-2834.
    View in: PubMed
    Score: 0.003
  42. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246.
    View in: PubMed
    Score: 0.003
  43. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res. 2019 Apr 01; 25(7):2194-2205.
    View in: PubMed
    Score: 0.003
  44. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998 Oct; 20(2):189-93.
    View in: PubMed
    Score: 0.003
  45. CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer. Sci Rep. 2018 06 21; 8(1):9427.
    View in: PubMed
    Score: 0.003
  46. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017 08 01; 109(8).
    View in: PubMed
    Score: 0.003
  47. Expression of a gene encoding a tRNA synthetase-like protein is enhanced in tumorigenic human myeloid leukemia cells and is cell cycle stage- and differentiation-dependent. Proc Natl Acad Sci U S A. 1997 Jun 10; 94(12):6164-9.
    View in: PubMed
    Score: 0.003
  48. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 1997 May 08; 14(18):2195-200.
    View in: PubMed
    Score: 0.003
  49. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Oncotarget. 2016 Aug 30; 7(35):56480-56490.
    View in: PubMed
    Score: 0.003
  50. Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases. Mol Cancer Ther. 2015 Dec; 14(12):2687-99.
    View in: PubMed
    Score: 0.003
  51. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One. 2015; 10(10):e0139049.
    View in: PubMed
    Score: 0.003
  52. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro. Cancer Genet Cytogenet. 1995 Jul 01; 82(1):35-40.
    View in: PubMed
    Score: 0.002
  53. High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients. BMC Cancer. 2014 Aug 31; 14:643.
    View in: PubMed
    Score: 0.002
  54. Microdissected double-minute DNA detects variable patterns of chromosomal localizations and multiple abundantly expressed transcripts in normal and leukemic cells. Genomics. 1994 Feb; 19(3):542-51.
    View in: PubMed
    Score: 0.002
  55. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines. Leuk Res. 1993 Aug; 17(8):639-47.
    View in: PubMed
    Score: 0.002
  56. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-?-driven epithelial-mesenchymal transition. Cancer Discov. 2013 Oct; 3(10):1172-89.
    View in: PubMed
    Score: 0.002
  57. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61.
    View in: PubMed
    Score: 0.002
  58. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog. 2014 Sep; 53(9):711-21.
    View in: PubMed
    Score: 0.002
  59. RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis. Int J Cancer. 2013 Jul 15; 133(2):275-85.
    View in: PubMed
    Score: 0.002
  60. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma. 2013; 60(2):135-42.
    View in: PubMed
    Score: 0.002
  61. Detection of extrachromosomal circular DNA sequences from tumor cells by an alkaline lysis, Alu-polymerase chain reaction technique. Mol Carcinog. 1992; 5(2):107-10.
    View in: PubMed
    Score: 0.002
  62. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas. 2011 Aug; 40(6):872-5.
    View in: PubMed
    Score: 0.002
  63. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol. 2011 Sep; 47(9):866-72.
    View in: PubMed
    Score: 0.002
  64. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Mol Carcinog. 2012 May; 51(5):433-8.
    View in: PubMed
    Score: 0.002
  65. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Cancer Prev Res (Phila). 2011 Jan; 4(1):137-49.
    View in: PubMed
    Score: 0.002
  66. Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates. Bioorg Med Chem. 2010 Sep 15; 18(18):6666-77.
    View in: PubMed
    Score: 0.002
  67. Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. J Cell Biol. 2010 Jul 12; 190(1):101-14.
    View in: PubMed
    Score: 0.002
  68. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010 Jun 15; 16(12):3171-81.
    View in: PubMed
    Score: 0.002
  69. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol. 2010 Feb; 36(2):395-403.
    View in: PubMed
    Score: 0.002
  70. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas. 2010 Jan; 39(1):1-4.
    View in: PubMed
    Score: 0.002
  71. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription. Int J Oncol. 2010 Jan; 36(1):39-48.
    View in: PubMed
    Score: 0.002
  72. A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors. Cancer Res. 2009 Sep 15; 69(18):7207-15.
    View in: PubMed
    Score: 0.002
  73. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med. 2009 May 26; 6(5):e1000068.
    View in: PubMed
    Score: 0.002
  74. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck. 2009 May; 31(5):625-34.
    View in: PubMed
    Score: 0.002
  75. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol. 2009 Feb; 16(2):431-9.
    View in: PubMed
    Score: 0.002
  76. Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Mod Pathol. 2008 Dec; 21(12):1428-35.
    View in: PubMed
    Score: 0.002
  77. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008 Oct 01; 100(19):1401-11.
    View in: PubMed
    Score: 0.002
  78. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Lett. 2008 Dec 08; 272(1):32-9.
    View in: PubMed
    Score: 0.002
  79. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res. 2007 May 15; 13(10):3100-4.
    View in: PubMed
    Score: 0.001
  80. Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol Carcinog. 2007 Apr; 46(4):249-56.
    View in: PubMed
    Score: 0.001
  81. Targeting aurora kinases as therapy in multiple myeloma. Blood. 2007 May 01; 109(9):3915-21.
    View in: PubMed
    Score: 0.001
  82. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Res. 2006; 34(21):6272-85.
    View in: PubMed
    Score: 0.001
  83. BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. J Biol Chem. 2004 May 07; 279(19):19643-8.
    View in: PubMed
    Score: 0.001
  84. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer. 2004 Jan 01; 100(1):12-9.
    View in: PubMed
    Score: 0.001
  85. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1518-22.
    View in: PubMed
    Score: 0.001
  86. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes. Oncogene. 2003 Jun 19; 22(25):3859-66.
    View in: PubMed
    Score: 0.001
  87. p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep. 2002 Aug; 3(8):767-73.
    View in: PubMed
    Score: 0.001
  88. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol. 2002 Feb; 22(3):874-85.
    View in: PubMed
    Score: 0.001
  89. Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin. Int J Oncol. 1999 Sep; 15(3):423-9.
    View in: PubMed
    Score: 0.001
  90. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13. Cancer Genet Cytogenet. 1998 Jul 15; 104(2):124-32.
    View in: PubMed
    Score: 0.001
  91. Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol. 1998 Jul 01; 56(1):7-13.
    View in: PubMed
    Score: 0.001
  92. Rearrangement of chromosome band 11q13 in HeLa cells. Anticancer Res. 1994 Sep-Oct; 14(5A):1727-33.
    View in: PubMed
    Score: 0.001
  93. KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp Hematol. 1992 Mar; 20(3):361-7.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.